Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08206 | 32205419 | Gut | Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. | 2020 | Details |
| A08207 | 32205261 | J Ethnopharmacol | Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor. | 2020 | Details |
| A08208 | 32205038 | Hepatobiliary Pancreat Dis Int | Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese. | 2020 | Details |
| A08209 | 32204538 | Nutrients | Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. | 2020 | Details |
| A08210 | 32203743 | Atherosclerosis | Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. | 2020 | Details |
| A08211 | 32202947 | Arch Physiol Biochem | All-Trans Retinoic Acid (atRA) effectively improves liver steatosis in a rabbit model of high fat induced liver steatosis. | 2020 | Details |
| A08212 | 32202088 | World J Mens Health | Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm. | 2020 | Details |
| A08213 | 32201176 | Gastroenterology | Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. | 2020 | Details |
| A08214 | 32200381 | Obes Facts | The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial. | 2020 | Details |
| A08215 | 32200254 | Biomed Pharmacother | Hepalatide ameliorated progression of nonalcoholic steatohepatitis in mice. | 2020 | Details |
| A08218 | 32198617 | Obes Surg | Hepatic Function and Fibrosis Assessment Via 2D-Shear Wave Elastography and Related Biochemical Markers Pre- and Post-Gastric Bypass Surgery. | 2020 | Details |
| A08219 | 32196896 | Diabetes Obes Metab | Incretin combination therapy for the treatment of non-alcoholic steatohepatitis. | 2020 | Details |
| A08220 | 32196885 | Liver Int | Non-amyloid liver involvement in familial Mediterranean fever: A systematic literature review. | 2020 | Details |
| A08221 | 32195455 | JHEP Rep | Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. | 2020 | Details |
| A08222 | 32194416 | Front Pharmacol | Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis. | 2020 | Details |
| A08223 | 32194141 | Immunol Lett | MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. | 2020 | Details |
| A08224 | 32193889 | Korean J Radiol | Development and Validation of a Simple Index Based on Non-Enhanced CT and Clinical Factors for Prediction of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A08225 | 32193478 | Sci Rep | The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index. | 2020 | Details |
| A08226 | 32192863 | Clin Breast Cancer | Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study. | 2020 | Details |
| A08227 | 32192511 | J Transl Med | Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study. | 2020 | Details |
| A08228 | 32192487 | Cell Commun Signal | FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity. | 2020 | Details |
| A08231 | 32192216 | Int J Mol Sci | PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice. | 2020 | Details |
| A08232 | 32191680 | Med Sci Monit | The p66shc-mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08233 | 32191646 | J Clin Invest | Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics. | 2020 | Details |
| A08234 | 32191577 | J Med Food | Eriocitrin Improves Adiposity and Related Metabolic Disorders in High-Fat Diet-Induced Obese Mice. | 2020 | Details |
| A08235 | 32191400 | Clin Pharmacol Drug Dev | Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function. | 2020 | Details |
| A08236 | 32191345 | Hepatology | Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling. | 2020 | Details |
| A08237 | 32190914 | Hepatology | Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. | 2020 | Details |
| A08238 | 32190823 | JHEP Rep | Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis. | 2020 | Details |
| A08239 | 32190810 | Curr Dev Nutr | Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort. | 2020 | Details |
| A08240 | 32190778 | Transl Gastroenterol Hepatol | Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates . | 2020 | Details |
| A08241 | 32190771 | Transl Gastroenterol Hepatol | Cholecystectomy does not worsen progression or outcomes in non-alcoholic fatty liver disease. | 2020 | Details |
| A08242 | 32190399 | Case Rep Surg | Biloma Secondary to Percutaneous Liver Biopsy Case Report. | 2020 | Details |
| A08243 | 32190149 | Arch Med Sci | Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis. | 2020 | Details |
| A08244 | 32189929 | J Clin Exp Hepatol | Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index. | 2019 | Details |
| A08245 | 32189926 | J Clin Exp Hepatol | Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment. | 2019 | Details |
| A08246 | 32189432 | J Cell Mol Med | A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors. | 2020 | Details |
| A08247 | 32189355 | J Food Biochem | Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice. | 2020 | Details |
| A08248 | 32189102 | Dig Dis Sci | Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu. | 2020 | Details |
| A08249 | 32188593 | BMJ Open Diabetes Res Care | Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism. | 2020 | Details |
| A08250 | 32188531 | J Dev Orig Health Dis | Administration of ursolic acid to new-born pups prevents dietary fructose-induced non-alcoholic fatty liver disease in Sprague Dawley rats. | 2020 | Details |
| A08251 | 32188385 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease and Vascular Disease. | 2021 | Details |
| A08252 | 32188134 | Int J Mol Sci | Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview. | 2020 | Details |
| A08253 | 32187572 | Environ Int | Long-term environmental exposure to microcystins increases the risk of nonalcoholic fatty liver disease in humans: A combined fisher-based investigation and murine model study. | 2020 | Details |
| A08254 | 32187014 | J Pediatr Endocrinol Metab | Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review. | 2020 | Details |
| A08255 | 32185692 | Indian J Gastroenterol | Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A08256 | 32185691 | Indian J Gastroenterol | The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08257 | 32185502 | Handb Exp Pharmacol | Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A08258 | 32184858 | Iran J Pharm Res | In-vitro Synergistic Effect of Metformin and Berberine on High Glucose-induced Lipogenesis. | 2019 | Details |
| A08259 | 32184641 | Diabetes Metab Syndr Obes | Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study. | 2020 | Details |
| A08260 | 32184638 | Diabetes Metab Syndr Obes | Lower Levels of Circulating Adiponectin in Elderly Patients with Metabolic Inflammatory Syndrome: A Cross-Sectional Study. | 2020 | Details |
| A08261 | 32184169 | Gene | Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
| A08262 | 32184095 | Clin Chim Acta | COX-2 in liver fibrosis. | 2020 | Details |
| A08263 | 32183383 | Diagnostics (Basel) | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan. | 2020 | Details |
| A08264 | 32181656 | J Agric Food Chem | Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1. | 2020 | Details |
| A08265 | 32181573 | Liver Int | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. | 2020 | Details |
| A08266 | 32181157 | Front Oncol | Effect of Non-alcoholic Fatty Liver Disease on the Risk of Synchronous Liver Metastasis: Analysis of 451 Consecutive Patients of Newly Diagnosed Colorectal Cancer. | 2020 | Details |
| A08267 | 32180556 | Mol Metab | Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes. | 2020 | Details |
| A08268 | 32179679 | Proc Natl Acad Sci U S A | Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. | 2020 | Details |
| A08270 | 32176760 | J Gastrointestin Liver Dis | Nonalcoholic Fatty Liver Disease as a Risk Factor for Prolonged Corrected QT Interval in Apparently Healthy Korean Women. | 2020 | Details |
| A08271 | 32176759 | J Gastrointestin Liver Dis | Association of Serum Homocysteine Levels with Histological Severity of NAFLD. | 2020 | Details |
| A08272 | 32175386 | Ann Transl Med | Scientometric analysis of mTOR signaling pathway in liver disease. | 2020 | Details |
| A08273 | 32175323 | Front Med (Lausanne) | Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08274 | 32172249 | Ann Nutr Metab | Exosomal miRNAs Profile in Children's Nonalcoholic Fatty Liver Disease and the Correlation with Transaminase and Uric Acid. | 2020 | Details |
| A08275 | 32171848 | Chem Biol Interact | Sphingolipids and the link between alcohol and cancer. | 2020 | Details |
| A08276 | 32171530 | Biochem Biophys Res Commun | Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway. | 2020 | Details |
| A08277 | 32171275 | BMC Pediatr | Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017. | 2020 | Details |
| A08279 | 32170962 | Hepatology | Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology. | 2020 | Details |
| A08280 | 32170895 | Liver Int | Prevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A08281 | 32170564 | Surg Endosc | Evaluation of the histological variability of core and wedge biopsies in nonalcoholic fatty liver disease in bariatric surgical patients. | 2020 | Details |
| A08282 | 32170127 | Sci Rep | Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice. | 2020 | Details |
| A08283 | 32169759 | Biomed Pharmacother | Gegen Qinlian Decoction abates nonalcoholic steatohepatitis associated liver injuries via anti-oxidative stress and anti-inflammatory response involved inhibition of toll-like receptor 4 signaling pathways. | 2020 | Details |
| A08284 | 32169461 | Clin Res Hepatol Gastroenterol | Gender differences in liver fibrosis among patients younger than 50 years: A retrospective cohort study. | 2020 | Details |
| A08285 | 32169430 | Gastroenterology | Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet. | 2020 | Details |
| A08286 | 32169417 | Biochem Pharmacol | Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A08287 | 32169080 | J Transl Med | Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway. | 2020 | Details |
| A08288 | 32168769 | Int J Mol Sci | Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08289 | 32168372 | Biochem J | Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics. | 2020 | Details |
| A08290 | 32168345 | PLoS One | Characterization of the immune cell landscape of patients with NAFLD. | 2020 | Details |
| A08291 | 32168133 | J Clin Gastroenterol | Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A08292 | 32166700 | J Endocrinol Invest | A preliminary study: proteomic analysis of exosomes derived from thyroid-stimulating hormone-stimulated HepG2 cells. | 2020 | Details |
| A08293 | 32166191 | Health Sci Rep | Noninvasive diagnosis in alcohol-related liver disease. | 2020 | Details |
| A08294 | 32166121 | Clin Exp Hepatol | Mac-2 binding protein in non-alcoholic fatty liver disease: Is it a reliable diagnostic biomarker? A pilot study. | 2020 | Details |
| A08295 | 32165444 | Diabetes Care | Intrahepatic Fat and Postprandial Glycemia Increase After Consumption of a Diet Enriched in Saturated Fat Compared With Free Sugars. | 2020 | Details |
| A08296 | 32165250 | J Hepatol | Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. | 2020 | Details |
| A08297 | 32164541 | BMC Gastroenterol | Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2020 | Details |
| A08298 | 32163832 | J Nutr Biochem | Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver. | 2020 | Details |
| A08299 | 32161549 | Front Pharmacol | Relationship Between Ginsenoside Rg3 and Metabolic Syndrome. | 2020 | Details |
| A08300 | 32161545 | Front Pharmacol | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities. | 2020 | Details |
| A08301 | 32161197 | JCI Insight | Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A08302 | 32160947 | Free Radic Biol Med | Mitochondrial superoxide/hydrogen peroxide: An emerging therapeutic target for metabolic diseases. | 2020 | Details |
| A08304 | 32160239 | PLoS One | Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. | 2020 | Details |
| A08305 | 32158763 | Front Med (Lausanne) | Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice. | 2020 | Details |
| A08306 | 32158445 | Front Immunol | CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism. | 2020 | Details |
| A08307 | 32158345 | Malays J Med Sci | Anti-Hypolipidemic and Anti-Oxidative Effects of Hydroalcoholic Extract of Origanum majorana on the Hepatosteatosis Induced with High-Fat Diet in Rats. | 2020 | Details |
| A08308 | 32158249 | Clin Exp Gastroenterol | Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2020 | Details |
| A08309 | 32158242 | Diabetes Metab Syndr Obes | DHA Protects Against Hepatic Steatosis by Activating Sirt1 in a High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model. | 2020 | Details |
| A08310 | 32157645 | J Gen Intern Med | Predictive Factors and Time to Development of Hepatic Decompensation in Patients with Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08311 | 32157523 | Obes Surg | Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds. | 2020 | Details |
| A08312 | 32156524 | Free Radic Biol Med | Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. | 2020 | Details |